There is extensive interest among scientists and others in whether and how research influences policy and practice. Because cancer care covers a continuum of health services from prevention and screening to treatment and outcomes, it provides an opportunity to investigate the intersection of research, policy, and practice at multiple levels.
In this symposium a panel of distinguished experts will present case studies across the cancer care continuum to demonstrate how research can influence policy and practice.
Following the presentations, there will be an opportunity for extended discussion between the audience and panel on the themes that emerge from the presentations, with an emphasis on the key lessons learned across the different examples.
Claire Snyder, PhD,Associate Professor of Medicine, Division of General Internal Medicine, Johns Hopkins School of Medicine
Deborah Kamin, RN, PhD, American Society of Clinical Oncology
Electra D. Paskett, PhD, Ohio State University
Jolie Ringash, MD, MsC, Princess Margaret Cancer Centre
Robert Smith, PhD, American Cancer Society
Separate registration fee required $45.00 for members and non-members, $20.00 for students and trainees.
The evening will start at 5:30 pm with a cash bar which will remain open during dinner.
5:30 pm Cash Bar Opens
6:00 pm Dinner will be served
6:30 pm Presentation to begin
7:45 pm Discussion
8:00 pm Conclusion
Claire Snyder, PhD, Associate Professor of Medicine, Division of General Internal Medicine, Johns Hopkins School of Medicine with joint appointments in Oncology and Health Policy & Management (Bloomberg School of Public Health). Dr. Snyder’s research focuses on the quality of cancer care, with emphasis in two areas: quality of life for cancer patients undergoing treatment and coordination of care for cancer survivors. She has conducted studies to investigate preventive and comorbid condition care in cancer survivors and has also applied her research to developing survivorship care strategies at Johns Hopkins. In other research, she is investigating whether having cancer patients complete questionnaires about their quality-of-life and supportive care needs, and providing that information to their clinicians, improves care quality. Dr. Snyder has held various leadership positions in international organizations focused on quality-of-life and quality-of-care. Previously, Dr. Snyder worked at the National Cancer Institute and edited Outcomes Assessment in Cancer: Measures, Methods, and Applications. She began her career at Covance Health Economics and Outcomes Services Inc.
Deborah Kamin, RN PhD, Senior Director, Cancer Policy and Clinical Affairs, American Society of Clinical Oncology. Dr. Kamin leads ASCO’s policy and advocacy programs, which span research, practice and health services issues. She promotes ASCO’s public policy positions with patient advocacy groups, medical specialty societies, government agencies, and congress. She has provided staff leadership for several of ASCO’s national policy initiatives, including the National Initiative on Cancer Care Quality (NICCQ), ASCO’s participation in the ABIM’s “Choosing Wisely” campaign, and oncology workforce analysis. Prior to joining ASCO, she directed health policy and benefit design for the Department of Defense civilian health insurance program, TRICARE, which covers 8 million beneficiaries.
Electra D. Paskett, PhD is the Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology in the College of Public Health and the Associate Director for Population Sciences and Program Leader of the Cancer Control Program in the Comprehensive Cancer Center of the Ohio State University (OSU). She is also Director of the Diversity Enhancement Program at the James Cancer Hospital. Dr. Paskett’s research is directed at cancer prevention, early detection and survivorship issues specifically among underserved populations. Dr. Paskett is the Principal Investigator of an NCI-funded P50, Center for Population Health and Health Disparities, to examine why rates of cervical cancer are high in Appalachia Ohio and was the Principal Investigator of the Ohio Patient Navigator Research Program. Dr. Paskett was elected as a Fellow to the American Association for the Advancement of Science in 2004. She is the past-President of the American Society of Preventive Oncology, a member of the NIH EPIC study section and chair of the Health Disparities Committee of the Alliance for Cooperative Trials in Oncology (ALLIANCE).
Jolie Ringash, MD, MSc, Professor, Radiation Oncology and Health Policy, Management and Evaluation at the University of Toronto and the Princess Margaret Cancer Centre (PMCC). Dr. Ringash has research interests in patient reported outcomes and quality of life, and she serves as co-chair of the Quality of Life Committee at the NCIC-Clinical Trials Group. She is chair of the QOL/Outcomes subcommittee of the PULA task force, under the auspices of the NCI Head and Neck Cancer Steering Committee. She also co-chairs the Head and Neck Cancer Survivorship program at the PMCC. She is a practicing radiation oncologist treating patients with neoplasms of the head and neck and gastrointestinal system. Her interests include the use of QOL data by patients, clinicians and decision-makers.
Robert Smith, PhD, is a cancer epidemiologist and Senior Director of Cancer Screening at the National Office of the American Cancer Society in Atlanta, Georgia. He also holds an appointment as Adjunct Professor of Epidemiology at the Rollins School of Public Health, Emory University School of Medicine. Dr. Smith’s primary research interests are cancer epidemiology, evaluation of cancer prevention and early detection programs, multi-chronic disease models of preventive care, and quality assurance in the delivery of health services. Prior to joining the ACS he held positions with the Boston University School of Public Health, and the United States Centers for Disease Control and Prevention. He serves on numerous international and national government and professional advisory committees and working groups. He co-chairs the National Colorectal Cancer Roundtable, and he was a founding member of Cervical Cancer Action, an international community of organizations and individuals dedicated to working collaboratively to eliminate cervical cancer deaths worldwide.